只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-06 2026-07-07 | SOPH SOPHiA GENETICS SA | Puylaert Kevin Officer · Chief Sales Officer | 卖出（S） | 31 | US$5.09 | US$157.67 | 147,948 | SEC |
| 2026-06-11 2026-06-15 | SERA SERA PROGNOSTICS, INC. | Aerts Austin Officer · Chief Financial Officer | 卖出（S） | 2,037 | US$2.01 | US$4,094.37 | 301,190 | SEC |
| 2026-06-09 2026-06-10 | SERA SERA PROGNOSTICS, INC. | Aerts Austin Officer · Chief Financial Officer | 卖出（S） | 5,440 | US$2.08 | US$11,315.20 | 303,227 | SEC |
| 2026-05-19 2026-05-20 | SOPH SOPHiA GENETICS SA | Puylaert Kevin Officer · Chief Sales Officer | 卖出（S） | 33 | US$4.54 | US$149.82 | 148,164 | SEC |
| 2026-04-20 2026-04-21 | SOPH SOPHiA GENETICS SA | Puylaert Kevin Officer · Chief Sales Officer | 卖出（S） | 33 | US$5.08 | US$167.64 | 148,197 | SEC |
| 2026-04-06 2026-04-08 | SOPH SOPHiA GENETICS SA | Puylaert Kevin Officer · Chief Sales Officer | 卖出（S） | 46 | US$4.86 | US$223.56 | 148,260 | SEC |
| 2026-04-06 2026-04-08 | SOPH SOPHiA GENETICS SA | Puylaert Kevin Officer · Chief Sales Officer | 卖出（S） | 30 | US$4.83 | US$144.90 | 148,230 | SEC |
| 2026-04-06 2026-04-08 | SOPH SOPHiA GENETICS SA | Puylaert Kevin Officer · Chief Sales Officer | 卖出（S） | 548 | US$4.86 | US$2,663.28 | 148,306 | SEC |
| 2026-03-31 2026-04-01 | SOPH SOPHiA GENETICS SA | Puylaert Kevin Officer · Chief Sales Officer | 卖出（S） | 3 | US$4.71 | US$14.13 | 92,383 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| AERTW | 131,678 | 0 | 168,026 | 78.37% | Q |
| AERT | 524.4674 | 0 | 1,333.4483 | 39.33% | Q, N |